02
Oct

Well-funded biotech Intarcia Therapeutics is rolling along with its ambitious plans to develop a diabetes treatment without Big Pharma’s help, posting positive results from two late-stage studies on its once-a-year drug-device combo.

…read more

Source: Intarcia’s annual diabetes treatment aces two Phase III trials

    

0 No comments